patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
EVEROLIMUS
Marketedupdated 2mo agoby Novugen Pharma (Malaysia) Sdn Bhd
Approvedcommunity read0 votes
all catalysts(6)
approval · 6
Mar 5, 2021
approval
EVEROLIMUS — FDA approval
EVEROLIMUS
→
Jun 22, 2023
approval
EVEROLIMUS — FDA approval
EVEROLIMUS
→
Jun 22, 2023
approval
EVEROLIMUS — FDA approval
EVEROLIMUS
→
Jun 22, 2023
approval
EVEROLIMUS — FDA approval
EVEROLIMUS
→
Jan 9, 2026
approval
EVEROLIMUS — FDA approval
EVEROLIMUS
→
Mar 6, 2026
approval
EVEROLIMUS — FDA approval
EVEROLIMUS
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that